Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 264 results found. Search for [ COVID-19 vaccine candidates ]

Results 1 to 21 of 264
BusinessToday.In
October 23, 2020
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective


PB Jayakumar
October 22, 2020
Serum Institute of India (SII) has teamed up with Merck KGaA, Germany, to develop COVID-19 fighting monoclonal antibodies (mAbs), made by cloning a unique white blood cell to increase immunity and fight diseases, along with drug research driven nonprofit scientific research organization IAVI and Scripps Research


BusinessToday.In
October 22, 2020
Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials


BusinessToday.In
October 22, 2020
Bharat Biotech Phase 3 trials: The volunteers would be given two doses of the experimental vaccine in a gap of 28 days


BusinessToday.In
October 21, 2020
PM Modi had said that India must not weaken the fight against coronavirus till a COVID-19 vaccine is developed and release for use


BusinessToday.In
October 20, 2020
Bill Gates says India's research and manufacturing will be critical to fighting Covid-19 especially when it comes to making vaccines at large scale; adds that vaccine development alone won't address problem as its production can throw various challenges


BusinessToday.In
October 20, 2020
Speaking during The Wall Street Journal's annual Tech Live conference on October 19, Moderna CEO Stephane Bancel said if satisfactory interim results from the study take longer to get, government authorisation of the COVID-19 vaccine may not happen until early next year


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 17, 2020
The shots planned for the initial phase would include a booster dose as well. The list comprises four categories of beneficiaries including frontline workers, healthcare professionals, people above 50, and people with comorbidities


BusinessToday.In
October 16, 2020
Pfizer and BioNTech's vaccine candidate, BNT162b2, is currently being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina


PTI
October 16, 2020
A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years


BusinessToday.In
October 15, 2020
Russian COVID-19 vaccine: Putin said on state TV that they have to increase production of first and second vaccines. \"We are continuing to cooperate with our foreign partners and will promote our vaccine abroad,\" he added


Reuters
October 14, 2020
While severe COVID-19 symptoms are extremely rare in infected children, they can pass on the virus to high-risk groups such as the elderly


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Biopharma company Epygen Biotech with operations in Mumbai and Dubai is planning to launch an affordable COVID-19 vaccine with an aim to roll out 500 million doses within six months


BusinessToday.In
October 13, 2020
Bangladesh has rejected the clinical trial of an experimental Chinese coronavirus vaccine which was being developed by Sinovac Biotech in the country


BusinessToday.In
October 13, 2020
\"We're expecting that early next year we should have vaccine in the country from maybe more than one source,\" says union health minister Harsh Vardhan


Reuters
October 12, 2020
The government did not disclose financial terms of the deal, its first vaccine purchase, which will provide enough doses to vaccinate 750,000 people


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


PTI
October 11, 2020
Harsh Vardhan said fighting COVID-19 is everyone's foremost \"dharma\" and as the country's health minister it is his \"dharma\" to mitigate the virus and prevent deaths at any cost


Associated Press
October 9, 2020
Initially, China did not agree to join the alliance, missing the global deadline to join in September


PAGES 1 OF 14  12345